Predicted loss and gain of function mutations in ACO1 are associated with erythropoiesis
- PMID: 32327693
- PMCID: PMC7181819
- DOI: 10.1038/s42003-020-0921-5
Predicted loss and gain of function mutations in ACO1 are associated with erythropoiesis
Abstract
Hemoglobin is the essential oxygen-carrying molecule in humans and is regulated by cellular iron and oxygen sensing mechanisms. To search for novel variants associated with hemoglobin concentration, we performed genome-wide association studies of hemoglobin concentration using a combined set of 684,122 individuals from Iceland and the UK. Notably, we found seven novel variants, six rare coding and one common, at the ACO1 locus associating with either decreased or increased hemoglobin concentration. Of these variants, the missense Cys506Ser and the stop-gained Lys334Ter mutations are specific to eight and ten generation pedigrees, respectively, and have the two largest effects in the study (EffectCys506Ser = -1.61 SD, CI95 = [-1.98, -1.35]; EffectLys334Ter = 0.63 SD, CI95 = [0.36, 0.91]). We also find Cys506Ser to associate with increased risk of persistent anemia (OR = 17.1, P = 2 × 10-14). The strong bidirectional effects seen in this study implicate ACO1, a known iron sensing molecule, as a major homeostatic regulator of hemoglobin concentration.
Conflict of interest statement
Authors affiliated with deCODE genetics/Amgen Inc., G.R.O., A.O., M.K.M., R.P.K., G.H.H., E.F., F.Z., A.H., E.V.I., G.A.A., B.O.J., H.K., G.S., A.M.K., A.L.L., J.S., L.S., J.K.S., O.B.D., S.B., As.J., Ad.J., S.J., R.L.G., V.T., B.G., G.M., G.T., T.R., H.H., D.F.G., G.L.N., U.T., P.S., and K.S. declare competing interests as employees. The remaining authors declare no competing interests.
Figures
References
-
- Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD). https://omim.org/ (2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
